Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
Year: 1991
Type: article
Source: PubMed
Authors: N K Cheung, L Burch, B H Kushner, D H Munn
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2423488844
